Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Appointments: G1 Therapeutics, Breath Therapeutics, Fortress Biotech, Freeline Therapeutics, Enterome and Symic Bio

Jul 14 2017

• By Lubna Ahmed

Related Companies

GSK plc

G1 Therapeutics Inc.

Fortress Biotech Inc.

Fortress Biotech Inc.

Nabriva Therapeutics plc.

Merck & Co., Inc.

Cubist Pharmaceuticals, Inc.

Spur Therapeutics Limited

Baxalta Incorporated

Novo Nordisk A/S

Bristol Myers Squibb Company

Astex Pharmaceuticals, Inc.

Astellas Pharma, Inc.

Astellas Pharma, Inc.

Arrowhead Pharmaceuticals, Inc.

Breath Therapeutics Holding BV

Cardeas Pharma Corporation

Gilead Sciences, Inc.

Symic Bio, Inc.

AstraZeneca PLC

Eli Lilly and Company

Affymetrix, Inc.

Enterome SA

Dimension Therapeutics

Additional Topics

Executive Changes BioPharmaceutical

More from Executives On The Move

More from Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window